Denver Infectious Disease Consultants, PLLC
Quick facts
Marketed products
- Raltegravir and Abacavir/Lamivudine · Infectious Disease / Virology
This combination inhibits HIV replication by blocking integrase (raltegravir) and reverse transcriptase (abacavir/lamivudine) at different stages of the viral lifecycle.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Denver Infectious Disease Consultants, PLLC portfolio CI brief
- Denver Infectious Disease Consultants, PLLC pipeline updates RSS
Frequently asked questions about Denver Infectious Disease Consultants, PLLC
What are Denver Infectious Disease Consultants, PLLC's marketed drugs?
Top marketed products include Raltegravir and Abacavir/Lamivudine.
Related
- Raltegravir and Abacavir/Lamivudine · Infectious Disease / Virology
- Sector hub: All tracked pharma companies